The following elements will have their visibility changed, please review the list before confirming the visibility change

Study

Study Name: Clostridium ultunense DSM 10521

Projects

Biosamples

Organisms

Biosamples: 0 Seq. Projects: 1
STUDY INFORMATION
GOLD Study ID Gs0004589
Study Name Clostridium ultunense DSM 10521
Other Names
NCBI Umbrella Bioproject Name
NCBI Umbrella Bioproject ID
SRA Studies
Legacy ER Study ID
Legacy GOLD ID
Added By Ionna Pagani on 2010-07-19
Last Modified By
PI
Description Clostridium ultunense DSM 10521 was purchased from DSMZ for genome sequencing, however 16S rDNA clone library constructed from this strain indicated that this strain was contaminated by a unknown strain related to Aminobacterium colombiense DSM 12261 (16S rDNA similarity>98%) and this result was confirmed by DSMZ. Clostridium ultunense DSM 10521 was enriched to about 70% abundance in the mix culture, which was used for DNA extraction and then 454 GS FLX Sequencing. Clostridium ultunense DSM 10521T was reported as a typical mesophilic syntrophic acetate oxidizer. In the project's biogas metagenome project (ID: 50503), a set of 16S rDNA sequences were closely matched to this species phylogenetically. Therefore, this strain was selected to sequence as a reference genome for this project.
Relevance Biotechnological
Study Information Link
Study Information Visibility Public
Metagenomic Study No
Publication
Is GEBA No
Is HMP No
ECOSYSTEM CLASSIFICATION
Ecosystem
Ecosystem Category
Ecosystem Type
Ecosystem Subtype
Specific Ecosystem
STUDY COMPOSITION
Number of Biosamples 0
Number of Organisms 1
Number of Seq Projects 1
Number of Analysis Projects 1
Number of Related Studies 0

 

 

  You are going to add the following user to ALL Sequencing Projects, Biosamples and Analysis Projects that
sit under this study (a cascading permission update).

 

Contact Name/Email:

Do you want to continue?

 

 

  You are going to remove permissions for the following user to all Sequencing Projects,
Biosamples and Analysis Projects under this study.

 

Contact Name/Email:

Do you want to continue?